↓ Skip to main content

Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial

Overview of attention for article published in Critical Care, June 2006
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
129 Dimensions

Readers on

mendeley
182 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial
Published in
Critical Care, June 2006
DOI 10.1186/cc4939
Pubmed ID
Authors

Bernd Muellejans, Thomas Matthey, Joachim Scholpp, Markus Schill

Abstract

Remifentanil is an opioid with a unique pharmacokinetic profile. Its organ-independent elimination and short context-sensitive half time of 3 to 4 minutes lead to a highly predictable offset of action. We tested the hypothesis that with an analgesia-based sedation regimen with remifentanil and propofol, patients after cardiac surgery reach predefined criteria for discharge from the intensive care unit (ICU) sooner, resulting in shorter duration of time spent in the ICU, compared to a conventional regimen consisting of midazolam and fentanyl. In addition, the two regimens were compared regarding their costs.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 182 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 3 2%
Italy 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 175 96%

Demographic breakdown

Readers by professional status Count As %
Other 29 16%
Researcher 27 15%
Student > Postgraduate 22 12%
Professor 15 8%
Student > Master 14 8%
Other 50 27%
Unknown 25 14%
Readers by discipline Count As %
Medicine and Dentistry 121 66%
Pharmacology, Toxicology and Pharmaceutical Science 8 4%
Nursing and Health Professions 5 3%
Agricultural and Biological Sciences 5 3%
Economics, Econometrics and Finance 4 2%
Other 10 5%
Unknown 29 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2015.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Critical Care
#4,397
of 6,554 outputs
Outputs of similar age
#30,042
of 88,191 outputs
Outputs of similar age from Critical Care
#14
of 26 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,554 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 88,191 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.